Possible hemophilia cure under study in Israeli hospital
US biotech company BioMarin enlists aid of Sheba Medical Center to take part in international trials of a ‘magic bullet’ treatment for hemophilia A.
US biotech company BioMarin enlists aid of Sheba Medical Center to take part in international trials of a ‘magic bullet’ treatment for hemophilia A.
Merger to produce new medications for sufferers of growth hormone deficiency, hemophilia, obesity and diabetes.